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Obstructive azoospermia is a relatively common male infertility condition. The main etiologies of obstructive
azoospermia include congenital, surgical-derived, traumatic and post-infectious cases. Although seminal tract
reconstruction is a cost-effective treatment in most cases, this approach may not be feasible or desired in some
cases. In such cases, assisted reproduction techniques offer a method for achieving pregnancy, notably via sperm
retrieval and intracytoplasmic sperm injection. This process requires several considerations and decisions to be
made, including the cause and duration of obstruction, which sperm retrieval technique to use, and whether to
use fresh or frozen-thawed sperm. We present a review of obstructive azoospermia and assisted reproduction
techniques, highlighting the most relevant aspects of the decision-making process for use in clinical practice.
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& INTRODUCTION
Azoospermia, defined as the complete absence of sperm
from the ejaculate, affects approximately 1% of all men and
5 to 10% of all subfertile males seeking care (1,2). Although
the majority of cases are secondary to an impairment of
testicular function, a bilateral obstruction of the male genital
tract causes azoospermia in up to 20 to 40% of cases (3).
We review the currently available data regarding sperm
retrieval in obstructive azoospermia (OA). Here, we present
the current status of the literature concerning sperm
retrieval and intracytoplasmic sperm injection (ICSI) out-
comes in relation to the cause of obstruction, the method of
sperm retrieval, and the gamete source.
& OBSTRUCTIVE AZOOSPERMIA: AN OVERVIEW
Obstructive azoospermia is defined as the absence of
spermatozoa in the ejaculate secondary to a physical
disruption of the seminal tract, which may be congenital
or caused by trauma (surgical or non-surgical) or infection.
Generally, spermatogenesis is fully preserved.
The absence of sperm on routine examination must be
confirmed by at least two semen samples collected 1-4
weeks apart and centrifuged at high speed (1500-1800 g for
15 min at room temperature) to distinguish azoospermia
from cryptozoospermia; otherwise, an equivocal diagnosis
may occur in up to 20% of cases (4,5). If retrograde
ejaculation is suspected, a post-ejaculate urine specimen
should be analyzed (6). Additional proposed criteria to
diagnose obstructive azoospermia include a normal hormo-
nal profile, normal-sized testis, and normal spermatogen-
esis, as evidenced by a testicular biopsy or an epididymal
aspirate full of spermatozoa (7).
Ninety-six percent of men with OA are found to have FSH
levels #7.6 mIU/mL or a testicular long axis .4.6 cm,
whereas 89% of men with non-obstructive azoospermia
(NOA) have FSH levels .7.6 mIU/mL or a testicular long
axis #4.6 cm (8).
In patients with OA, although normal spermatogenesis is
preserved, the quality of spermatozoa may be altered
because the distal epididymis contains a high number of
sperm fragments with macrophages (9). The number of
macrophages progressively decreases toward the proximal
epididymis and testis, while the quantity of motile sperm
gradually increases. The concentration of motile spermato-
zoa in the epididymal fluid can be as high as 1 million
sperm per mL (10).
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Vasectomy comprises the main cause of OA, and 2 to 6%
of vasectomized men will seek reversal to restore fertility. In
these cases, microsurgical reconstruction by either vasova-
sostomy or vasoepididimostomy is the standard of care (11-
13). There is compelling evidence that vasectomy reversal is
a more cost-effective approach than in vitro fertilization
(IVF) for vasectomy-related OA (14,15). However, the final
therapeutic decision should be individualized for each
couple, as certain situations (e.g., significant female factor
infertility or social factors) may favor sperm retrieval (SR)
and IVF as more suitable treatment options.
Both men with OA who are not candidates for reconstruc-
tive surgery and those who fail to achieve success with such
procedures have been historically considered hopelessly
infertile. However, with the first reports of successful
pregnancies achieved by the use of IVF in the early 1990s, a
new perspective emerged (16,17). Currently, IVF is an
established assisted reproductive technique (ART) with
consistent results. The Society of Assisted Reproductive
Technology (SART) publishes yearly data on the effective-
ness of IVF in different patient populations. A total of 17% of
all IVF cycles from 2000 to 2008 were performed due to male
factor infertility. The live birth rate associated with the use of
IVF is increasing. In fact, the delivery rate across all age
groups increased from 34.5% in 2003 to 37.3% in 2008. The
use of ICSI for male factor infertility also increased from 84 to
87% during this time period. Data from SART, however, do
not offer fine enough resolution to distinguish IVF treatments
undertaken for obstructive versus non-obstructive azoosper-
mia (15,18). In Latin America, the latest report from the Red
Latinoamericana de Reproducio´n Asistida (RedLara) in 2009
noted ICSI and IVF procedure proportions of 85 and 15%,
respectively; a total of 27,174 IVF/ICSI cycles were initiated,
resulting in 7,141 live births (19). Again, it is not possible to
determine the proportion of such treatments applied to men
with OA.
As the number of ART procedures performed is expected
to increase with the anticipated increase in the current 15%
incidence of infertility over the next 20 years (20), some
questions have emerged regarding the state-of-the-art
methods used to perform sperm retrieval for use in IVF/
ICSI.
& THE IMPACT OF ETIOLOGY ON RETRIEVAL
SUCCESS AND REPRODUCTIVE OUTCOMES
AFTER ICSI
Common causes of OA include previous vasectomy,
congenital bilateral absence of the vas deferens (CBAVD),
infectious epididymitis/orchitis, Young’s Syndrome, and
testicular trauma (21). Some authors include ejaculatory
dysfunctions in the OA category, including retrograde
ejaculation and anejaculation (7,21). The appropriateness
of the inclusion of these conditions in the OA category is,
however, debatable, as there is no anatomical barrier
precluding sperm from being ejaculated in these conditions.
The most common cause of iatrogenic ductal obstruction
is vasectomy. Although vasectomy reversal is achievable in
many cases, the scope of this review will be limited to
vasectomized men who failed reconstruction or opted for
sperm retrieval procedures associated with IVF treatment.
After vasectomy, testicular histology changes, as noted by
the presence of fibrosis and decreased spermatid number,
which worsen with longer periods of obstruction; as such,
pregnancy rates with ART treatment might also decline
(22). In a study by Sukcharoen et al. comprising 17 patients
and 21 ICSI cycles within a period of two years, subjects
were divided into three groups according to the time
elapsed since vasectomy: 0-10 years, 11-20 years, or more
than 20 years. No difference could be found regarding
fertilization rates (FRs), implantation rates (IRs), and
pregnancy rates (PRs) between the groups. The authors of
the aforementioned study concluded that the interval
between vasectomy and surgical sperm retrieval associated
with ICSI treatment had no impact on pregnancy outcomes,
although it should be noted that the analyzed sample was
small and likely lacked statistical power to enable
definitive conclusions (23).
Congenital unilateral (CUAVD) and bilateral (CBAVD)
absence of the vas deferens and congenital obstruction of
the epididymides are all part of the spectrum of vasal
aplasia. CBAVD affects 2% of infertile men and has been
described as a primary genital form of cystic fibrosis (5).
Approximately 80% of CBAVD patients exhibit definable
mutations within at least one allele of the cystic fibrosis
transmembrane conductance regulator (CFTR) gene, which
is located on the short arm of chromosome 7 (24). This
gene encodes a protein that functions as an ion channel but
also affects the formation of the distal 2/3 of the
epididymis, vas deferens, seminal vesicle and ejaculatory
duct. An additional 10 to 15% of men with vasal aplasia
exhibit renal anomalies (e.g., agenesis, failure of assent,
and ectopia). The diagnosis of vasal aplasia must be
suspected in infertile men with a low semen volume and
with a low pH as a consequence of the absence of the
seminal vesicles. Spermatogenesis in CBAVD appears
normal, but sperm derived from the caput epididymis
are thought to have a low fertilizing capacity in conven-
tional IVF cycles because of their short passage through
the epididymis (25). All men with CBAVD should be
assumed to harbor CFTR mutations, as a negative genetic
test does not rule out the mutation with 100% accuracy
due to the gene length and testing limitations. However,
genetic screening should be offered to the female partner
because a 25 to 50% risk of inheritance of cystic fibrosis
exists if she also carries a mutation (26). Because
spermatogenesis is not altered by this condition, sperm
can be retrieved from both the testicle and the epididymis
without difficulty. In an earlier study by Chen et al. (27), 31
patients with obstructive azoospermia underwent epidi-
dymal aspiration procedures associated with ART (includ-
ing IVF, zygote intra-Fallopian transfer, subzonal
insemination). The fertilization rate for caput spermatozoa
was lower than that for spermatozoa derived from other
areas of the epididymis (p,0.05). In the aforementioned
study, the CBAVD group exhibited a higher probability to
achieve pregnancy compared with the acquired obstruc-
tion group (20 versus 5.9%, p.0.05). Currently, ICSI is
used rather than conventional IVF after sperm retrieval
because sperm injection has been shown to result in a
significantly higher fertilization rate (28).
Ejaculatory duct abnormalities can also result in obstruc-
tion. Congenital ejaculatory duct obstruction (EDO) repre-
sents an anomaly caused by maldevelopment of the portion
of the Wolffian ductal system that courses through the
central zone of the prostate and enters the prostatic urethra.
Mu¨llerian duct and prostatic utricle cysts can extrinsically
compress the ejaculatory ducts and result in obstruction
Etiology, retrieval technique and gamete source
Miyaoka R and Esteves SC
CLINICS 2013;68(S1):111-119
112
(29). Acquired EDO causes include chronic prostatitis,
prostatic calcification, prior prostatic biopsy, and iatrogenic
damage to the ejaculatory ducts during urethral instrumen-
tation (6,30). Transurethral resection of the ejaculatory ducts
(TURED) has been the classic treatment for this disorder.
Alternatively, sperm retrieval can be attempted with ICSI.
Epididymal, testicular, and transperineal seminal vesical
sperm retrievals have been applied in such cases with
adequate yields of motile sperm for either immediate use
with ICSI or cryopreservation (31). In cases of ejaculatory
dysfunction, spermatogenesis is fully preserved, and
gametes can be recovered either from the urine (in cases
of retrograde ejaculation) or from the epididymides or
testicles with any chosen surgical sperm retrieval technique
(in cases of primary anorgasmia or failed urinary sperm
recovery).
In a recent study, Esteves et al. (32) reported a
cumulative sperm retrieval success rate (SRR) of 97.9%
using percutaneous epididymal sperm aspiration (PESA),
in association or not with testicular sperm aspiration
(TESA), in men with OA, regardless of the cause of
obstruction. PESA alone was able to retrieve sperm in
more than 80% of the cases. Reproductive outcomes after
ICSI were not affected by the source (epididymis versus
testicle) or etiology (congenital, failed vasectomy reversal,
post-infectious disease). Successful epididymal sperm
retrievals were achieved in all congenital obstructive
cases, whereas testicular retrievals were needed in
approximately 1/3 of the cases classified in the other
etiology groups (vasectomy, post-infectious obstructions).
In a meta-analysis involving 756 ICSI cycles using
surgically retrieved sperm, Nicopoullos et al. compared
the outcomes of ICSI between patients with congenital and
acquired OA. The meta-analysis revealed no difference in
either clinical pregnancy rate (relative risk [RR]: 1.03; 95%
confidence interval [CI]: 0.75-1.31; p= 0.87) or live birth rate
(RR: 1.03; 95% CI: 0.81-1.31; p= 0.80) between patients with
congenital and acquired cases of OA. A significantly higher
fertilization rate was noted in the acquired group (RR: 0.92;
95% CI: 0.84-1; p= 0.05), while a significantly higher
miscarriage rate (MR) was noted in the congenital group
(RR: 2.67). The authors concluded that in ICSI cycles for men
with OA, the cause of OA appears to influence the outcome,
with higher FRs and lower MRs observed in patients with
acquired OA. However, tests of heterogeneity were sig-
nificant, and it should be noted that the studies included
had no power to detect clinically significant differences in
the analyzed outcomes (21).
A more recent and larger series conducted by Kamal et al.
involved 1,661 ICSI cycles in 1,121 men with proven
histological OA. The outcomes were compared according
to the sperm retrieval source and cause of obstruction. The
fertilization rates (68.0% versus 64.2%, p= 0.02), implanta-
tion rates (19.9% versus 20.8%, p= 0.41), and frequencies of
clinical pregnancies (43.2% versus 42.3%, p= 0.84) and
miscarriages (18.4% vs. 17.6%, p= 1.0) resulting from the
use of testicular and epididymal spermatozoa, respectively,
were comparable in ICSI. Similar rates were maintained
after stratification according to the cause of obstruction
(CBAVD versus acquired obstruction), suggesting that
neither the origin of surgically retrieved spermatozoa nor
the cause of obstruction have any significant effect on the
success of IVF/ICSI (7).
& IMPACT OF THE METHOD OF COLLECTION ON
RETRIEVAL SUCCESS AND REPRODUCTIVE
OUTCOMES AFTER ICSI
The method of choice for sperm retrieval is based on the
attending surgeon’s preferences and the preferences of the
embryologist involved in the patient’s care. In a meta-
analysis by Van Peperstraten et al., the technique for sperm
retrieval (microsurgical epididymal sperm aspiration
[MESA] versus epididymal micropuncture with perivascular
nerve stimulation and ultrasound-guided TESA versus
conventional TESA) and the sperm source (testis, epididymis,
vas deferens, or seminal vesicle) did not seem to play a role in
the pregnancy rates achieved with IVF/ICSI (33). All
methods have been shown to provide sufficient viable sperm
for ICSI and often also for cryopreservation (34).
The use of surgical techniques for sperm retrieval in OA
men, as well as the use of retrieved spermatozoa in IVF
treatments, dates back to the 1980s with the description of
MESA by Temple-Smith et al. (35). Thereafter, many other
techniques have been developed, including those meant to
extract sperm from the epididymis and from the testis. Their
use varies according to the azoospermia etiology and
specific scenarios (36). Sperm retrieval should focus on
three main goals:
1. To retrieve an adequate number of sperm for both
immediate use and cryopreservation;
2. To obtain the highest quality sperm possible;
3. To minimize damage to the reproductive tract to not
jeopardize future sperm retrieval attempts or testicular
function (36,37).
Several authors have examined the effectiveness of
percutaneous procedures for sperm retrieval in OA. Sperm
retrieval rates have been quoted at approximately 100%
when percutaneous epididymal and testicular retrievals are
combined (38-43) (Table 1). Glina et al. reported a series of
58 men with OA treated with ICSI who underwent
percutaneous epididymal sperm retrievals (with rescue
TESA whenever needed). The authors reported 100%
recovery of motile sperm using these combined techniques.
Successful repeated PESA was performed up to three times,
with recovery of motile sperm in over 80% of the cases.
Forty-three percent of PESA procedures yielded sufficient
spermatozoa to allow cryopreservation (42). Esteves et al.
reported a SRR of 97.9% among 142 men with OA. In these
series, TESA as a rescue procedure after a failed PESA was
performed in 17% of the cases. One-third of the retrievals
yielded a sufficient number of spermatozoa for cryopreser-
vation (32). Lin et al. analyzed 100 men with irreparable OA
who underwent 109 ICSI cycles. The PESA SRR was 61%.
MESA or testicular sperm extraction (TESE) were success-
fully performed if PESA failed. Fertilization and pregnancy
rates were not significantly different for PESA-ICSI cycles
(56 and 39%, respectively) and MESA-ICSI cycles (47 and
45%, respectively) (43). Despite the notably lower SRR for
PESA the authors’ data corroborate the ability to perform
rescue procedures in cases of initial failure.
The reasons for epididymal retrieval failures include
obstructions at the level of the rete testis, which, according
to Pryor (44), can be found in up to 15% of OA men. Such
individuals have normal spermatogenesis but no clinical
findings suggestive of obstruction. Even grossly distended
CLINICS 2013;68(S1):111-119 Etiology, retrieval technique and gamete source
Miyaoka R and Esteves SC
113
Table 1 - Studies reporting sperm retrieval efficacy and/or pregnancy outcomes in men with obstructive azoospermia.
Author Country Design
No. of
cycles
Mean Paternal
Age (years) Outcome Main findings Conclusion
Rosenlund
et al. 1998
Sweden Retrospective NR 37 Recovery of
viable sperm on
repeated PESA
High sperm recovery
rates were found
on repeated PESA
up to 4 times
PESA is simple, offers a high
sperm recovery rate and can
be safely repeated in OAmen,
yielding similar SRR results.
Levine et al.
1998
USA Retrospective 37 NR Efficacy and safety of
percutaneous sperm
retrieval and ICSI
outcomes (CPR) using
retrieved sperm
Efficacy and safety of
percutaneous sperm
retrieval techniques (PESA,
TESA) were demonstrated
PESA and TESA are more
effective alternatives
compared with the more
invasive MESA approach.
Dohle et al.
1998
The
Netherlands
Retrospective 39 38.1 ICSI outcomes (ongoing
pregnancy rates) using
percutaneously or
surgically-retrieved sperm
Both percutaneously
and surgically retrieved
spermatozoa provide
adequate pregnancy
outcomes.
High fertilization rate
was obtained after ICSI
regardless of the
retrieval method
Janzen et al.
2000
USA Retrospective 108 38.3 ICSI outcomes (CPR) using
fresh or frozen
epididymal sperm
Both fresh and cryo-
thawed epididymal sperm
harvested by MESA
yielded similar CPR
Comparable pregnancy
outcomes for fresh and
frozen epididymal sperm,
with logistic-related
advantages for frozen sperm
Glina et al.
2003
Brazil Retrospective 79 45 Success at obtaining
sperm by PESA
and CPR after ICSI
High SRR on repeated
PESA up to 4 times
PESA is simple, offers a high
sperm retrieval rate and
can be safely repeated in
men with OA.
Westlander
et al. 2001
Sweden Retrospective 22 34.8 ICSI outcomes up
to ongoing pregnancy/
delivery rates
after TESA
TESA can be repeated
with no negative
impact on the recovery
of mature spermatozoa
or pregnancy outcome
Repeated TESA is safe and
effective
Levine et al.
2003
USA Retrospective 112 37.1 ICSI
outcomes (CPR) after
percutaneous sperm
retrieval
PESA and TESA are
highly effective
for sperm retrieval
and offer similar
pregnancy outcomes
with ICSI.
Percutaneous sperm
aspiration is effective,
safe and reproducible
Dozortsev
et al. 2006
Brazil Retrospective 185 NR ICSI outcomes (ongoing
pregnancy rates) with
percutaneous sperm
retrieval
Higher FR in the
PESA group and higher
implantation rate in the
TESA group were reported;
trends toward higher PR
and lower miscarriage rate
in the TESA group
Embryo development was
significantly better when
testicular sperm was
used for ICSI
Pasqualotto
et al. 2006
Brazil Retrospective 155 NR ICSI outcomes according
to etiology of OA
Higher FR and
implantation rate in
men with congenital
OA; similar PR in all
etiology categories
No impact of etiology
of OA on CPR
Garg et al.
2008
USA Retrospective 38 39.1 ICSI outcomes (LBR)
using TESA
TESA is highly effective
in recovering motile
spermatozoa and
offers adequate
pregnancy outcomes.
TESA is an effective means
of recovering mature
motile sperm which are
suitable for cryopreservation
in most cases.
Kamal et al.
2010
Egypt, The
Netherlands,
United
Kingdom
Retrospective 1,661 39.2 ICSI outcomes (CPR)
according to sperm
source and etiology
of obstruction
Similar pregnancy
outcomes for different
sperm sources (testicular
or epididymal) and
causes of obstruction
(congenital or acquired)
The source of sperm and
the etiology of obstruction
do not seem to influence
pregnancy and miscarriage
rates.
Kalsi et al.
2010
United
Kingdom
Retrospective 258 NR ICSI outcomes (live
birth rate) using fresh
or frozen-thawed
retrieved sperm
Higher pregnancy
and live birth rates
were reported for frozen-
thawed compared with
fresh sperm
No negative impact of using
frozen-thawed epididymal
or testicular sperm for ICSI; a
tendency for higher PR and
live birth rate associated
with frozen-thawed
testicular sperm
SRR: sperm retrieval rate; ICSI: intracytoplasmic sperm injection; IVF: in vitro fertilization; PESA: percutaneous epididymal sperm aspiration; TESA:
testicular sperm aspiration; MESA: microsurgical epididymal sperm aspiration; FR: fertilization rate; PR: pregnancy rate; CPR: clinical pregnancy rate; LBR:
live birth rate; NR: not reported.
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epididymides represent a poor clinical sign of obstruction
and can be misleading. Successful epididymal sperm
retrieval in these cases can be achieved in approximately
70% of cases (40). The PESA SRR is influenced by the
anatomical conformation of the epididymis, and PESA may
be more difficult in small and loosely attached epididy-
mides, which can make isolation more difficult. Needle
width can also affect the results and must be selected
properly. Levine et al. reported their experience using a 23-
gauge butterfly needle to aspirate spermatozoa from the
epididymis with satisfactory sperm quantity for ICSI use
(45). In a study by Mallidis and Baker (46) comparing
devices for fine needle tissue aspiration biopsy of the testis,
the authors observed that the 20-gauge biopsy needles with
stylet penetrated easier within the testis and caused the least
amount of tissue distortion.
Repeat percutaneous procedures have been associated
with successful sperm retrieval. Repeated PESA up to three
times on the same unilateral epididymis with equivalent
fertilization rates was described as being successful by
Rosenlund et al. in a retrospective series involving 27 men
with OA or ejaculatory dysfunction (47). Sperm retrieval
rates of 91, 89, and 86% were reported at the first, second
and third PESA, respectively. Repeated TESA has also been
reported to yield SRRs of 100 and 96% for first and second
attempts, respectively. No significant impacts on fertiliza-
tion rates were observed by the authors of the study.
PESA and TESA have some disadvantages compared with
open surgical sperm retrievals (36). Both methods have an
increased risk of hematoma compared with open techniques
(48). Nevertheless, except for minor pain and local swelling,
there are no reports of clinically significant perioperative or
postoperative complications leading to medical treatment or
hospital care when percutaneous techniques are used. The
time interval between the procedures (classified as less than
three months, three to six months, andmore than six months)
did not influence the outcome (sperm recovery, fertilization,
and pregnancy rates). It should be noted, however, that the
TESA technique is not standardized in the published studies,
and in most centers, TESA is considered a rescue procedure
for OA cases (48,49).
Other factors associated with the preference for one
technique over the other include the quantity of retrieved
spermatozoa and the ability to cryopreserve the excess
retrieved sperm. PESA has been associated with better
recovery of motile spermatozoa compared with testicular
retrieval (TESA) (100% versus 39.3%, p,0.0001) in patients
with azoospermia or severe oligozoospermia (33). However,
the ability to cryopreserve excess retrieved sperm is lowest
in percutaneous compared with open sperm retrievals (33).
Interestingly, Garg et al. (50) reported a 97.5% success rate
in motile sperm recovery that was adequate for intentional
cryopreservation in 40 men with either OA or ejaculatory
dysfunction using TESA. Cryopreservation is important
because it prevents the need for future retrieval procedures
in the event that ICSI fails.
& IMPACT OF GAMETE SOURCE (EPIDIDYMIS OR
TESTICLE) ON REPRODUCTIVE OUTCOMES WITH
ICSI
As stated earlier, spermatozoa can be recovered from
either the epididymis or the testicle with a high probability
of success in men diagnosed with obstructive azoospermia,
regardless of the cause. In early ICSI series, the fertilization
and pregnancy rates using surgically retrieved spermato-
zoa obtained from the epididymis or testis were compar-
able to the results of ejaculated sperm (51,52). As both
sources were proven adequate for ICSI, the possible
treatment outcome advantages of one over the other have
been explored.
Testicular sperm aspiration pregnancy rates with ICSI are
reportedly as high as 31%, with a calculated delivery rate of
27% considering a miscarriage rate of 11.6% (38). Similarly,
pregnancy rates with ICSI using epididymal sperm are
reported to be as high as 43%, with a calculated delivery rate
of 38% if a similar miscarriage rate is assumed (53-55). In a
meta-analysis by Nicopoullos et al. (56), fertilization rates
were reported to vary from 45 to 72% for epididymal and 34
to 81% for testicular sperm. No differences in cleavage, PRs
or IRs were reported in any of the individual articles.
Relative risk (RR) ratios of 1.08, 1.01, and 0.71 were
described for the fertilization rate, clinical pregnancy rate
and live birth rate, respectively, for epididymal compared
with testicular sperm (p.0.05). The authors of the afore-
mentioned studies therefore concluded that when a diag-
nosis of OA is made, epididymal aspiration should be the
retrieval method of choice in view of the possible
complications of testicular extraction, including inflamma-
tion, hematoma, devascularization (57) and decreased
serum testosterone levels (58).
Similar results were reported by Kamal et al. (7) in a large
cohort involving 1,121 patients with OA undergoing ICSI.
These authors argued that the preferential use of testicular
sperm or epididymal sperm in cases of OA is unfounded, as
neither the source nor the etiology seems to affect sperm
injection outcomes.
Conversely, Dozortsev et al. reported higher FRs using
spermatozoa retrieved from the epididymis compared with
the testis in OA cases (77.2 versus 67.5%, p= 0.0005).
However, patients in the testicular sperm group exhibited
significantly higher IR (20.8 versus 32.8%, p= 0.008), with a
trend toward higher ongoing PR and lower miscarriage rate.
These authors speculate that motile sperm randomly taken
from the epididymis have lower reproductive potential than
random sperm taken from the testicle, and argue that the
prolonged presence of sperm within the epididymis may
lead to structural chromosomal aberrations that can
compromise the reproductive potential of the such cells
(59). To corroborate these findings, recent studies have
demonstrated that epididymal sperm exhibit more DNA
damage than sperm retrieved directly from the testis. The
frequency of terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labeling (TUNEL)-positive cells
according to the sperm cell origin has been reported as
follows: 9.3¡2.3% in the testis, 17.4¡4.0% in the epididy-
mis, and 29.2¡6.7% in the vas deferens (60,61). Despite
these reports, sperm retrieved directly from the testis are
generally limited in number and are often immotile or non-
progressively motile, although they are still viable and
almost always functional for use in ART (48).
& IMPACT OF GAMETE STATUS (FRESH OR
FROZEN-THAWED) ON REPRODUCTIVE
OUTCOMES AFTER ICSI
The cryopreservation of epididymal and testicular sperm
offers the advantage of a single retrieval procedure for
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sperm collection, thereby enabling the use of stored
spermatozoa in multiple IVF cycles. Cryopreservation
avoids the logistical difficulties associated with attempts to
coordinate sperm retrieval and ART on the same day and
permits infectious triage prior to insemination (48).
However, cryopreservation has been shown to negatively
affect motility, acrosome integrity, acrosin activity, and
morphology of both testicular and ejaculated spermatozoa.
For example, Prabakaran et al. noted a 25% decrease in post-
thaw testicular sperm motility (62). Decreased sperm
morphology, mitochondrial function, and viability have
also been described by O’Connell et al. after testicular sperm
cryopreservation and thawing (63). The cryopreservation
and thawing process has also been associated with the lipid
peroxidation of sperm plasma membranes, which may
facilitate free radical oxygen species access to sperm nuclei
and ultimately disrupt DNA integrity (64).
Despite these potential downsides, the clinical pregnancy
rate of 141 ICSI cycles using frozen-thawed (n= 33) or fresh
(n = 108) spermatozoa retrieved from men with OA were
comparable (60.6% vs. 66.7%, respectively) in the series of
Jansen et al. (65). Garg et al. (50) also reported similar
fertilization rates and biochemical pregnancy rates resulting
from the use of frozen-thawed or fresh testicular sperma-
tozoa. Conversely, a significantly higher clinical pregnancy
rate was observed for fresh epididymal sperm versus
frozen-thawed counterparts in a meta-analysis study,
despite the fact that the fertilization (RR: 1.02; 95% CI:
0.96-1.08; p= 0.61) and implantation (RR: 1.20; 95% CI: 1.0-
1.42; p= 0.05) potential of both gametes were equivalent (33).
Intriguingly, a recent retrospective study by Kalsi et al.
compared 493 ICSI cycles with the use of fresh versus frozen
sperm by stratifying results according to the testicular and
epididymal sources. Unexpectedly higher PR (60.0% versus
32.1%, p,0.05) and live birth rate (60.0% versus 28.6%,
p,0.05) were observed for frozen-thawed testicular sperm
compared with fresh testicular sperm. The miscarriage rates
were equivalent (25.0% versus 29.2% for fresh and frozen-
thawed sperm, respectively) (66).
& ASSESSMENT OF CHILDREN BORN WITH ICSI
USING SPERM RETRIEVED FROM MEN WITH OA
Concern has been raised regarding the risk of using non-
ejaculated spermatozoa in assisted reproduction.
Epididymal sperm may be immature or senescent because
of the long stay in the obstructed epididymis, which may
lead to genetic risks if these sperm are used for fertilization
(61). Testicular sperm, in turn, have the potential risk of
incomplete genomic imprinting, incomplete chromatin
condensation, and incomplete protamination (67,68).
In a recent Dutch prospective, multicenter study by
Woldringh et al. (69), 378 children born from ICSI cycles
using retrieved epididymal sperm were evaluated. More
than 1,000 children born as a result of ICSI or IVF using
ejaculated sperm were available for comparison.
Assessments were performed at birth and at 1 and 4 years
of age using mailed questionnaires. Moreover, follow-up
visits of 2-year-old children were carried out to evaluate
motor performance and mental-language development. The
epididymal sperm group did not exhibit a higher incidence
of stillbirths, malformations or poor development compared
with the reference group of children born after ICSI or IVF
using ejaculated sperm.
& EXPERT COMMENTARY
In a group of 2,383 infertile men attending our tertiary
center for male reproduction, 835 (35%) were identified as
having azoospermia; approximately 36% of those cases
resulted from obstruction in the ductal system.
The adoption of strict criteria to diagnose OA is crucial for
obtaining a high retrieval success rate in the range of 90-
100% using percutaneous techniques. In our experience,
percutaneous sperm retrieval is a highly effective method
for collecting sperm in men with OA. Successful sperm
retrieval was achieved in over 85% of the cases using PESA,
but more than one aspiration was often required (32). In
cases of failed PESA, TESA was adequate to obtain sperm in
nearly all cases. Motile spermatozoa were obtained in
approximately 73% of the cases after the first or second
PESA aspiration, and TESA was performed as a rescue
procedure after failed PESA in approximately 14% of the
individuals (32). Our results show that ICSI outcomes using
spermatozoa collected by PESA or TESA are similar, thus
suggesting that the reproductive potential of those gametes
is independent of their source in OA. However, epididymal
spermatozoa are easier to handle in the IVF laboratory
compared with testicular sperm, and it is more likely that
there will be excess sperm for freezing if epididymal
retrievals are performed. In our group of men with OA,
fertilization and live birth rates did not differ between
individuals who had vasectomy/failed reversal, CBAVD or
infection as the cause of obstruction (32).
Despite the fact that higher rates of sperm cryopreserva-
tion have been reported for open sperm retrieval compared
to percutaneous retrieval, the costs of the former procedure
are significantly higher. Cryopreservation is important
because it prevents the need for future retrieval procedures
in the case that ICSI fails. However, if needed, repeat
percutaneous procedures result in successful sperm retrie-
val. This is encouraging because the need for open
procedures is lessened. It is debatable whether percuta-
neous retrievals are more cost-efficient than MESA, and no
study to date has compared the cumulative pregnancy rate
per couple using repeat percutaneous retrievals and fresh
sperm injections with a single MESA attempt and inten-
tional sperm cryopreservation for use in multiple subse-
quent ICSI attempts.
Percutaneous sperm retrieval techniques can be per-
formed for both diagnostic and therapeutic purposes. For
the latter purpose, sperm retrieval is often performed on the
same day of oocyte retrieval or on the preceding day. Using
PESA, our approach is to perform the first aspiration at the
epididymis corpus and proceed to the caput if necessary
because aspirates from the cauda are usually of poor quality
and contain senescent spermatozoa, debris, and macro-
phages. Most cases of PESA failures are not necessarily
technical failures because immotile spermatozoa is usually
retrieved. As a diagnostic procedure, the presence of
spermatozoa at the time of percutaneous epididymal
retrieval has shown to have 93% sensitivity and 94%
specificity to diagnose obstructive azoospermia (70).
Usually, percutaneous sperm retrievals are performed on
an outpatient basis. Patients are discharged one hour later
and can return to normal activities the following day. Oral
analgesics are prescribed, but pain complaints are minimal.
The most common complication is fibrosis at the aspiration
site. Other potential complications include hematoma,
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bleeding and infection, but these complications are rare. On
rare occasions, we perform MESA for sperm retrieval in OA
men with coagulation disorders.
While PESA is sufficient for the majority of patients, TESA
is needed for more difficult cases. We noted that signifi-
cantly fewer men with CBAVD required a TESA procedure
compared with the post-infectious and vasectomy groups.
Our results indicate that PESA is sufficient for sperm
retrieval in CBAVD cases but that TESA will need to be
performed in approximately 1/3 of cases in the other
etiology groups (32). In our series, the higher percentage of
vasectomy and post-infectious patients, compared to those
with congenital obstruction, requiring a rescue TESA
procedure after the initial failed epididymal attempt is
likely due to the epididymis being obstructed after
vasectomy or failed reversals or being severely damaged
after infection, thus making it difficult to percutaneously
retrieve motile sperm. The concept of cryopreservation may
be used in association with sperm retrieval procedures.
Epididymal and testicular spermatozoa can be cryopre-
served using protocols routinely used for ejaculated sperm.
Some centers prefer to retrieve and intentionally cryopre-
serve sperm for future use. If sperm are frozen, thawing can
be performed at any time, thus obviating the need to
organize two operations (oocyte and sperm retrieval) on the
same day. Additionally, cryopreservation may be an
interesting method for storing leftover specimens that
would otherwise be discarded after ICSI, especially if the
treatment cycle does not result in a pregnancy. Future ICSI
attempts may be performed without repeated surgical
retrievals. We routinely freeze excess motile epididymal
spermatozoa that are not needed for the current ICSI cycle.
Most often, motile sperm will be available after thawing in
such cases, and ICSI outcomes using motile fresh or frozen
epididymal sperm do not appear to differ.
The best currently available evidence regarding the
influence of the cause of obstruction on ICSI results is
provided by a meta-analysis that was entirely based on a
retrospective heterogenic series (21). Therefore, further
studies are needed, particularly studies with a prospective
design. Moreover, few studies have considered the impact
of maternal age on fecundity. Vasectomy reversal may not
be the first line therapy for couples in which the female
partner is of advanced maternal age because sperm retrieval
and ICSI expedites the time to pregnancy and delivery.
Moreover, when analyzing studies that compare pregnancy
outcomes, it must be noted that a significant proportion of
them consider only the results achieved for the first ICSI
cycle. These results can be misleading, as success can be
achieved in subsequent cycles as a result of optimized
ovarian stimulation of the female partner or the replacement
of cryopreserved embryos.
Finally, there is little high-quality evidence on short- and
long-term pregnancy outcomes with ICSI using spermato-
zoa from men with OA. From the limited data available, no
major differences have been reported in the short-term
neonatal outcomes of children born from such fathers. ICSI
with epididymal sperm does not lead to a higher incidence
of stillbirths or congenital malformations compared with
IVF and ICSI with ejaculated sperm and does not lead to
poor childhood development (69). In this sense, the Dutch
follow-up study is reassuring, but obtaining more data on
fetal, neonatal and long-term outcomes should be identified
as a major research priority.
Due to the importance of obstructive azoospermia in the
context of male infertility, there is a need for the execution of
well-designed multi-center studies with adequate sample
sizes and follow-up durations, the development of standard
data sets to enable the differentiation of men into the various
OA subgroups, the consideration of the cause of obstruction
and the source of the male gamete, and the use of control
groups of children conceived naturally or with ICSI using
ejaculated sperm. For now, the continued monitoring of
children born after ICSI using non-ejaculated sperm from
men with OA should be set as the minimum standard.
& KEY ISSUES
N In men with OA, sperm production is normal, and
gametes can be easily retrieved from the epididymis or
testis in the vast majority of cases.
N The sperm retrieval technique and the cause of obstruc-
tion have little impact on sperm retrieval success rates.
N Percutaneous sperm retrievals are simple and effective
methods for collecting epididymal or testicular sperma-
tozoa in OA. TESA should be performed as a rescue
procedure because TESA may impose a higher risk of
complications.
N MESA may yield a higher number of motile sperm but
is not demonstrably cost-effective and is more techni-
cally demanding compared with percutaneous retrieval
methods.
N The time interval since vasectomy and the paternal age
do not seem to affect the sperm retrieval success rate or
pregnancy outcomes from sperm injections.
N The current evidence demonstrates equivalent preg-
nancy outcomes in OA men when comparing epididy-
mal and testicular sperm, fresh and frozen-thawed
sperm, and different causes of obstruction.
N Sperm chromatin integrity seems to be decreased toward
the distal portion of an obstructed seminal tract.
N Motile sperm retrieved from men with OA should be
cryopreserved whenever possible for future use, thereby
sparing men from unnecessary procedures.
N No major difference has been reported in the short-term
neonatal outcomes of children born from fathers with
OA. ICSI performed with epididymal sperm does not
lead to a higher rate of stillbirths or congenital
malformations compared with IVF and ICSI with
ejaculated sperm and does not lead to poor childhood
development. However, the current data are limited, and
the continued monitoring of children born to OA fathers
is of utmost importance.
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